Hepatitis B Virus
Agenix Completes $6.72 Million Rights Issue
Published in Hepatitis Weekly, June 4th, 2007
Agenix announces the successful completion of its $6.72 million capital raising to fund the sales and marketing launch of the anti-hepatitis B virus drug of SHRG, the Chinese bio-pharmaceutical company which Agenix is in the process of acquiring. The SHRG acquisition comprises two related private companies established in the People's Republic of China which are engaged in developing a pipeline of biopharmaceutical products and own a GMP manufacturing facility.
The most developed product is an anti-hepatitis B virus drug which has successfully completed Phase III clinical trials and is expected to be launched on the Chinese market in the second half of calendar year...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-06-04)
More Articles from Hepatitis Weekly
- Bird Flu
Wistar Institute Launches New Vaccine Center - Hepatitis C Virus
Could statins be a new option for hepatitis C patients? - Liver Cancer
The hepatitis C link: Diagnose, treat, transplant - Cancer Vaccines
Inovio Biomedical Partner Tripep Provides Update on its Hepatitis C DNA Vaccine Program - Hepatitis B Virus
Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients - Hepatitis B Virus
FDA Approves Gen-Probe's Automated PROCLEIX TIGRIS System to Test Donated Blood With the PROCLEIX ULTRIO Assay - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
